EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY
Equipe constitutive du CERPOP, UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
Pacale GROSCLAUDE •  chercheure

  1. Banh Chong T, Grosclaude P, Chabrillac E, Lozano S, Vergez S, Mourey L, Dupret-Bories A. Outcomes of comprehensive geriatric assessment and surgical management in head and neck cancers of the elderly: an observational study. Eur Arch Otorhinolaryngol. 2023 Jan;280(1):329-338. doi: 10.1007/s00405-022-07559-5.
  2. Colonna M, Grosclaude P, Bouvier AM, Goungounga JA, Jooste V. Reply to "Survivorship experience: More than premature mortality from cancer". Cancer. 2023 Mar 1;129(5):805-806. doi: 10.1002/cncr.34581.
  3. Demeulemeester R, Savy N, Grosclaude P, Costa N, Saint-Pierre P. Agent based modeling in health care economics: examples in the field of thyroid cancer. Int J Biostat. 2023 Jul 3. doi: 10.1515/ijb-2022-0107. Epub ahead of print.
  4. Demuru E, Rossi S, Ventura L, Dal Maso L, Guzzinati S, Katalinic A, Lamy S, Jooste V, Di Benedetto C, De Angelis R; EUROCARE-6 Working Group (Grosclaude P collaborator). Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes. Front Oncol. 2023 Apr 24;13:1114701. doi: 10.3389/fonc.2023.1114701.
  5. Gimenez L, Grosclaude P, Druel V, Costa N, Delpierre C, Molinier L, Delord JP, Rougé Bugat ME. Study protocol of the CREDO randomised controlled trial: evaluation of a structured return home consultation for patients suffering from metastaticcancer. BMJ Open. 2023 Jan 30;13(1):e062219. doi: 10.1136/bmjopen-2022-062219.
  6. Martinet-Kosinski F, Lamy S, Bauvin E, Dalenc F, Vaysse C, Grosclaude P. The stake of informing patients of the risk of hypofertility after chemotherapy for breast cancer. Front Public Health. 2023 Mar 3;11:1129198. doi: 10.3389/fpubh.2023.1129198.
  7. Martinet-Kosinski F, Lamy S, Bauvin E, Dalenc F, Vaysse C, Grosclaude P. Access to information and oncofertility consultation for young women with breast cancer: a population-based study. Sci Rep. 2023 Feb 27;13(1):3313. doi: 10.1038/s41598-023-30423-3.
  8. Ouanhnon L, Bugat MR, Druel V, Grosclaude P, Delpierre C. Link between the referring physician and breast and cervical cancers screening: a cross-sectional study in France. BMC Prim Care. 2023 Aug 29;24(1):167. doi: 10.1186/s12875-023-02122-5.
  9. Renou A, Guizard AV, Chabrillac E, Defossez G, Grosclaude P, Deneuve S, Vergez S, Lapotre-Ledoux B, Plouvier SD, Dupret-Bories A, Francim Network. Evolution of the Incidence of Oral Cavity Cancers in the Elderly from 1990 to 2018. J Clin Med. 2023 Jan 30;12(3):1071. doi: 10.3390/jcm12031071.
  1. Assogba ELF, Dumas A, Woronoff AS, Mollévi C, Coutant C, Ladoire S, Desmoulins I, Dabakuyo-Yonli TS; French Network of Cancer Registries (FRANCIM) (Grosclaude P collaborator). Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocol. BMJ Open. 2022 Sep 28;12(9):e056834. doi: 10.1136/bmjopen-2021-056834.
  2. Bejarano-Quisoboni D, Pelletier-Fleury N, Allodji RS, Lacour B, GrosClaude P; FRANCIM Group; Pacquement H, Doz F, Berchery D, Pluchart C, Bondiau PY, Nys J, Jackson A, Demoor-Goldschmidt C, Dumas A, Thomas-Teinturier C, Vu-Bezin G, Valteau-Couanet D, Haddy N, Fresneau B, de Vathaire F. Health care expenditures among long-term survivors of pediatric solid tumors: Results from the French Childhood Cancer Survivor Study (FCCSS) and the French network of cancer registries (FRANCIM). PLoS One. 2022 May 26;17(5):e0267317. doi: 10.1371/journal.pone.0267317.
  3. Chabrillac E, Lamy S, Grosclaude P, Cros F, Vairel B, Sarini J, Vergez S, Nebout A, Bories P, Dupret-Bories A. The impact of physician's characteristics on decision-making inhead and neck oncology: Results of a national survey. Oral Oncol. 2022 Jun;129:105895. doi: 10.1016/j.oraloncology.2022.105895.
  4. Colonna M, Grosclaude P, Bouvier AM, Goungounga J, Jooste V. Health status of prevalent cancer cases as measured by mortality dynamics (cancer vs. noncancer): Application to five major cancers sites. Cancer. 2022 Oct;128(20):3663-3673. doi: 10.1002/cncr.34413.
  5. Daubisse-Marliac L, Grosclaude P, Carulla M, Parada D, Vilardell L, Ameijide A, Marcos-Gragera R, Galceran J. Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make It More Useful? Int J Environ Res Public Health. 2022 Feb 25;19(5):2714. doi: 10.3390/ijerph19052714.
  6. Druel V, Gimenez L, Tachousin P, Boussier N, Bauvin E, Grosclaude P, Beyne-Rauzy O, Rougé Bugat ME. Adapting patients' oncological treatment through remote participation of general practitioners in multi-disciplinary consultation meetings: A feasibility study. Eur J Gen Pract. 2022 Dec;28(1):15-22. doi: 10.1080/13814788.2021.2003775.
  7. Gimenez L, Druel V, Bonnet A, Delpierre C, Grosclaude P, Rouge-Bugat ME. Experimental system of care coordination for the home return of patients with metastatic cancer: a survey of general practitioners. BMC Prim Care. 2022 Nov 17;23(1):283. doi: 10.1186/s12875-022-01891-9.
  8. Jooste V, Bengrine-Lefevre L, Manfredi S, Quipourt V, Grosclaude P, Facy O, Lepage C, Ghiringhelli F, Bouvier AM. Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice. Cancers (Basel). 2022 Mar 25;14(7):1675. doi: 10.3390/cancers14071675.
  9. Mathelin C, Barranger E, Boisserie-Lacroix M, Boutet G, Brousse S, Chabbert-Buffet N, Coutant C, Daraï E, Delpech Y, Duraes M, Espié M, Fornecker L, Golfier F, Grosclaude P, Hamy AS, Kermarrec E, Lavoué V, Lodi M, Luporsi É, Maugard CM, Molière S, Seror JY, Taris N, Uzan C, Vaysse C, Fritel X. Indications des mastectomies de réduction de risque en dehors du risque avéré de prédisposition héréditaire : recommandations du Collège national des gynécologues et obstétriciens français (CNGOF) [Non-genetic indications for risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)]. Gynecol Obstet Fertil Senol. 2022 Feb;50(2):107-120. French. doi: 10.1016/j.gofs.2021.12.005.
  10. Martinez A, Daubisse-Marliac L, Lacaze JL, Pons-Tostivint E, Bauvin E, Delpierre C, Grosclaude P, Lamy S; EvaSein Group. Treatment time interval in breast cancer: A population-based study on the impact of type and number of cancer centres attended. Eur J Cancer Care (Engl). 2022 Nov;31(6):e13654. doi: 10.1111/ecc.13654.
  11. Ouanhnon L, Rougé Bugat ME, Lamy S, Druel V, Delpierre C, Grosclaude P. Social and territorial inequalities in breast and cervical cancers screening uptake: a cross-sectional study in France. BMJ Open. 2022 Feb 22;12(2):e055363. doi: 10.1136/bmjopen-2021-055363.
  12. Talibov M, Tual S, Morlais F, Meryet-Figuière M, Boulanger M, Bouvier V, Perrier S, Clin B, Baldi I, Lebailly P; AGRICAN group (Grosclaude P collaborator). Colorectal cancer among farmers in the AGRICAN cohort study. Cancer Epidemiol. 2022 Jun;78:102125. doi: 10.1016/j.canep.2022.102125.
  13. Vener C, Rossi S, Minicozzi P, Marcos-Gragera R, Poirel HA, Maynadié M, Troussard X, Pravettoni G, De Angelis R, Sant M; EUROCARE-6 Working Group (Grosclaude P collaborator). . Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials. Front Oncol. 2022 Jul 14;12:892684. doi: 10.3389/fonc.2022.892684.
  1. Baicry F, Molinié F, Plouvier S, Colonna M, Daubisse-Marliac L, Grosclaude P, Trétarre B, Bara S, Lapôtre-Ledoux B, Woronoff AS, Guizard AV, Bouvier V, Troussard X, Marrer E, Klein D, Velten M, Jégu J. What is the most appropriate period to define synchronous cancers? Cancer Epidemiol. 2021 Apr;71(Pt A):101900. doi: 10.1016/j.canep.2021.101900.
  2. Biscond M, Guimbaud R, Digue L, Cirilo-Cassaigne I, Bousser V, Oum-Sack E, Goddard J, Bauvin E, Delpierre C, Grosclaude P, Lamy S. How does comorbidity affect colon cancer patients' care trajectory? Results from the French EvaCCoR cohort study. Clin Res Hepatol Gastroenterol. 2021 Jan;45(1):101422. doi: 10.1016/j.clinre.2020.03.022.
  3. Chatignoux E, Uhry Z, Grosclaude P, Colonna M, Remontet L. How to produce sound predictions of incidence at a district level using either health care or mortality data in the absence of a national registry: the example of cancer in France. Int J Epidemiol. 2021 Mar 3;50(1):279-292. doi: 10.1093/ije/dyaa217.
  4. Cros F, Lamy S, Grosclaude P, Nebout A, Chabrillac E, Vergez S, Bories P, Dupret-Bories A. Physician practice variation in head and neck cancer therapy: Results of a national survey. Oral Oncol. 2021 Jun;117:105293. doi: 10.1016/j.oraloncology.2021.105293.
  5. Defossez G, Uhry Z, Delafosse P, Dantony E, d'Almeida T, Plouvier S, Bossard N, Bouvier AM, Molinié F, Woronoff AS, Colonna M, Grosclaude P, Remontet L, Monnereau A; French Network of Cancer Registries (FRANCIM). Cancer incidence and mortality trends in France over 1990-2018 for solid tumors: the sex gap is narrowing. BMC Cancer. 2021 Jun 24;21(1):726. doi: 10.1186/s12885-021-08261-1.
  6. Durand MA, Lamouroux A, Redmond NM, Rotily M, Bourmaud A, Schott AM, Auger-Aubin I, Frachon A, Exbrayat C, Balamou C, Gimenez L, Grosclaude P, Moumjid N, Haesebaert J, Massy HD, Bardes J, Touzani R, Diant LBEF, Casanova C, Seitz JF, Mancini J, Delpierre C. Impact of a health literacy intervention combining general practitioner training and a consumer facing intervention to improve colorectal cancer screening in underserved areas: protocol for a multicentric cluster randomized controlled trial. BMC Public Health. 2021 Sep 16;21(1):1684. doi: 10.1186/s12889-021-11565-3.
  7. Foucan AS, Grosclaude P, Bousser V, Bauvin E, Smith D, Andre-Fardeau C, Daubisse-Marliac L, Mathoulin-Pelissier S, Amadeo B, Coureau G. Management of colon cancer patients: A comprehensive analysis of the absence of multidisciplinary team meetings in two French departments. Clin Res Hepatol Gastroenterol. 2021 Mar;45(2):101413. doi: 10.1016/j.clinre.2020.02.020.
  8. Girardi F, Rous B, Stiller CA, Gatta G, Fersht N, Storm HH, Rodrigues JR, Herrmann C, Marcos-Gragera R, Peris-Bonet R, Valkov M, Weir HK, Woods RR, You H, Cueva PA, De P, Di Carlo V, Johannesen TB, Lima CA, Lynch CF, Coleman MP, Allemani C; CONCORD Working Group (Grosclaude P collaborator). The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3). Neuro Oncol. 2021 Oct 1;23(10):1765-1776. doi: 10.1093/neuonc/noab067.
  9. Xiao D, Guizard AV, Daubisse-Marliac L, Woronoff AS, Trétarre B, Delafosse P, Molinié F, Cowppli-Bony A, Lapôtre-Ledoux B, Bara S, Marrer E, Velten M, Laroche L, Heutte N, Grosclaude P, Joly F. Evaluation of long-term living conditions in patients treated for localised prostate cancer. Eur J Cancer Care (Engl). 2021 Jan;30(1):e13333. doi: 10.1111/ecc.13333.
  1. Bielska-Lasota M, Rossi S, Krzyżak M, Haelens A, Domenic A, De Angelis R, Maciejczyk A, Rodríguez-Barranco M, Zadnik V, Minicozzi P, EUROCARE-5 Working Group (Grosclaude P collaborator). Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study. Arch Gynecol Obstet. 2020;301(2):591‐602. doi:10.1007/s00404-019-05412-5.
  2. Biscond M, Guimbaud R, Digue L, Cirilo-Cassaigne I, Bousser V, Oum-Sack E, Goddard J, Bauvin E, Delpierre C, Grosclaude P, Lamy S. How does comorbidity affect colon cancer patients' care trajectory? Results from the French EvaCCoR cohort study [published online ahead of print, 2020 Apr 16]. Clin Res Hepatol Gastroenterol. 2020;S2210-7401(20)30097-8. doi:10.1016/j.clinre.2020.03.022.
  3. Bouvier AM, Robaszkiewicz M, Jooste V, Cariou M, Drouillard A, Bouvier V, Nousbaum JB, French Network of Cancer Registries (FRANCIM) (Grosclaude P collaborator). Trends in incidence of small bowel cancer according to histology: a population-based study. J Gastroenterol. 2020;55(2):181‐188. doi:10.1007/s00535-019-01636-z.
  4. Dal Maso L, Panato C, Tavilla A, Guzzinati S, Serraino D, Mallone S, Botta L, Boussari O, Capocaccia R, Colonna M, Crocetti E, Dumas A, Dyba T, Franceschi S, Gatta G, Gigli A, Giusti F, Jooste V, Minicozzi P, Neamtiu L, Romain G, Zorzi M, De Angelis R, Francisci S; EUROCARE-5Working Group (Grosclaude P collaborator). Cancer cure for 32 cancer types: results from the EUROCARE-5 study. Int J Epidemiol. 2020 Oct 1;49(5):1517-1525.. doi: 10.1093/ije/dyaa128.

  5. Druel V, Gimenez L, Paricaud K, Delord JP, Grosclaude P, Boussier N, Rougé Bugat ME. Improving communication between the general practitioner and the oncologist: a key role in coordinating care for patients suffering from cancer. BMC Cancer. 2020;20(1):495. doi:10.1186/s12885-020-06993-0.
  6. Gimenez L, Druel V, Roques S, Vasseur J, Grosclaude P, Delpierre C, Rouge-Bugat ME. Inventory of tools for care coordination between general practice and hospital system for patients suffering from cancer in active phase of treatment: A scoping review. Eur J Cancer Care (Engl). 2020 Nov;29(6):e13319. doi: 10.1111/ecc.13319.
  7. Grosclaude P, Azria D, Guimbaud R, Thibault  S, Daubisse  L, Cartron  G, Renaudie  MJ, Dalbies PA, Delord JP, Bauvin E. Impact du SARS-CoV2 sur la structuration de la prise en charge du cancer : exemple de la tenue des RCP de cancérologie en Occitanie [COVID-19 impact on the cancer care structuration: example of the multidisciplinary team meeting dedicated to oncology in Occitanie] [published online ahead of print, 2020 May 18]. Bull Cancer. 2020;10.1016/j.bulcan.2020.05.001. doi:10.1016/j.bulcan.2020.05.001.
  8. Pons-Tostivint E, Grosclaude P, Daubisse-Marliac L. Reply to Ivica Ratosa et al. Comment on: "Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter study". Breast. 2020 Oct;53:42. doi: 10.1016/j.breast.2020.06.006.
  9. Sant M, Meneghini E, Bastos J, Rossi PG, Guevara M, Innos K, Katalinic A, Majuelo LG, Marcos-Gragera R, Molinié F, Rapiti E, Vizcaino A, Zadnik V, Minicozzi P; European High Resolution Working Group on breast cancer (Grosclaude P collaborator). Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study. Breast Cancer Res Treat. 2020 Sep;183(2):439-450. doi: 10.1007/s10549-020-05761-9.
  10. Villers A, Bessaoud F, Trétarre B, Grosclaude P, Malavaud B, Rebillard X, Iborra F, Daubisse L, Malavaud S, Roobol M, Heijnsdijk  EA, de Koning HJ, J Hugosson J, Rischmann P, Soulié M. Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC). Prog Urol. 2020;30(5):252‐260. doi:10.1016/j.purol.2020.02.011.
  11. Uhry Z, Chatignoux E, Dantony E, Colonna M, Roche L, Fauvernier M, Defossez G, Leguyader-Peyrou S, Monnereau A, Grosclaude P, Bossard N, Remontet L. Multidimensional penalized splines for incidence and mortality-trend analyses and validation of national cancer-incidence estimates. Int J Epidemiol. 2020 Aug 1;49(4):1294-1306. doi: 10.1093/ije/dyaa078.
  1. Bielska-Lasota M, Rossi S, Krzyżak M, et al  EUROCARE-5 Working Group (Grosclaude P collaborator). Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study [published online ahead of print, 2019 Dec 18]. Arch Gynecol Obstet. 2019;10.1007/s00404-019-05412-5. doi:10.1007/s00404-019-05412-5.
  2. Bouvier AM, Robaszkiewicz M, Jooste V, et al. French Network of Cancer Registries (FRANCIM (Grosclaude P collaborator). Trends in incidence of small bowel cancer according to histology: a population-based study [published online ahead of print, 2019 Oct 19]. J Gastroenterol. 2019;10.1007/s00535-019-01636-z. doi:10.1007/s00535-019-01636-z
  3. Bryere J, Tron L, Menvielle G, Launoy G; French Network of Cancer Registries (FRANCIM) (Grosclaude P collaborator). The respective parts of incidence and lethality in socioeconomic differences in cancer mortality. An analysis of the French network Cancer registries (FRANCIM) data. Int J Equity Health. 2019 Dec 3;18(1):189. doi: 10.1186/s12939-019-1087-y.
  4. Cowppli-Bony A, Colonna M, Ligier K, Jooste V, Defossez G, Monnereau A; le Réseau Francim; Réseau des registres de cancer Francim. Grosclaude P collaborator) [Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence]. Bull Cancer. 2019. Jul-Aug 106 (7-8), 617-63. doi: 10.1016/j.bulcan.2018.11.016.
  5. Gatta G, Trama A, Capocaccia R; RARECARENet Working Group. (Grosclaude P collaborator) Epidemiology of rare cancers and inequalities in oncologic outcomes. Eur J Surg Oncol. 2019 Jan;45(1):3-11. doi: 10.1016/j.ejso.2017.08.018.
  6. Gosset A, Cohade C, Grosclaude P, Oumsack E, Dalenc F, Montagut M, Parinaud J, Vaysse C. [Regional state-of-the-art of the access to oncofertility consultation for young women with breast cancer]. Gynecol Obstet Fertil Senol. 2019 Oct;47(10):732-738. doi:10.1016/j.gofs.2019.08.005.
  7. Imbimbo M, Maury JM, Garassino M, Girard N; RARECAREnet Working Group. (Grosclaude P collaborator)  Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting. Eur J Surg Oncol. 2019 Jan;45(1):75-80. doi: 10.1016/j.ejso.2018.01.078.
  8. Lamy S, Guimbaud R, Digue L, Cirilo-Cassaigne I, Bousser V, Oum-Sack E, Goddard J, Bauvin E, Delpierre C, Grosclaude P; EvaCCoR Group. Are there variations in adherence to colorectal cancer clinical guidelines depending on treatment place and recommendation novelty? The French EvaCCoR observational study. Clin Res Hepatol Gastroenterol. 2019 Jun;43(3):346-356. doi: 10.1016/j.clinre.20110.008.
  9. Lamy S, Laurent G, Lepage B, Grosclaude P, Delpierre C. Impact of comorbidity in DBLCL: direct and indirect effects on survival through unplanned chemotherapy dose reduction. J Intern Med. 2019 Apr;285(4):472-474. doi: 10.1111/joim.12879.
  10. Lamy S, Molinié F, Daubisse-Marliac L, Cowppli-Bony A, Ayrault-Piault S, Fournier E, Woronoff AS, Delpierre C, Grosclaude P. Using ecological socioeconomic position (SEP) measures to deal with sample bias introduced by incomplete individual-level measures: inequalities in breast cancer stage at diagnosis as an example. BMC Public Health. 2019 Jul 2;19(1):857. doi: 1186/s12889-019-7220-4.
  11. Lykoudis PM, Partelli S, Muffatti F, Caplin M, Falconi M, Fusai GK; RARECARENet Working Group. (Grosclaude P collaborator) Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours. Eur J Surg Oncol. 2019 Jan;45(1):46-51. doi: 10.1016/j.ejso.2017.08.019.
  12. Nicolai N, Biasoni D, Catanzaro MA, Colecchia M, Trama A; RARECAREnet Working Group. (Grosclaude P collaborator) Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference. Eur J Surg Oncol. 2019 Jan;45(1):60-66. doi: 10.1016/j.ejso.2018.02.006.
  13. Orlandi E, Alfieri S, Simon C, Trama A, Licitra L; RARECAREnet Working Group. (Grosclaude P collaborator) Treatment challenges in and outside a network setting: Head and neck cancers. Eur J Surg Oncol. 2019 Jan;45(1):40-45. doi: 10.1016/j.ejso.2018.02.007.
  14. Pasquali S, Bonvalot S, Tzanis D, Casali PG, Trama A, Gronchi A; RARECARENet Working Group. (Grosclaude P collaborator) Treatment challenges in and outside a network setting: Soft tissue sarcomas. Eur J Surg Oncol. 2019 Jan;45(1):31-39. doi: 10.1016/j.ejso.2017.09.015.
  15. Piel C, Pouchieu C, Carles C, Béziat B, Boulanger M, Bureau M, Busson A, Grüber A, Lecluse Y, Migault L, Renier M, Rondeau V, Schwall X, Tual S; AGRICAN group (Grosclaude P collaborator), Pierre L, Baldi I. Agricultural exposures to carbamate herbicides and fungicides and central nervous system tumour incidence in the cohort AGRICAN. Environ Int. 2019 Sep;130:104876. doi:10.1016/j.envint.2019.05.070.
  16. Pons-Tostivint E, Daubisse-Marliac L, Grosclaude P, Oum Sack E, Goddard J, Morel C, Dunet C, Sibrac L, Lagadic C, Bauvin E, Bergé Y, Bernard-Marty C, Vaysse C, Lacaze JLL; EvaSein Group. Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter study. Breast. 2019 Aug;46:170-177. doi: 10.1016/j.breast.2019.06.001.
  17. Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA; RARECARENet Working Group. (Grosclaude P collaborator). Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. Eur J Surg Oncol. 2019 Jan;45(1):67-74. doi: 10.1016/j.ejso.2009.025.
  18. Tual S, Busson A, Boulanger M, Renier M, Piel C, Pouchieu C, Pons R, Perrier S, Levêque-Morlais N, Karuranga P, Lemarchand C; AGRICAN-Group (Grosclaude P collaborator), Marcotullio E, Guizard AV, Monnereau A, Baldi I, Lebailly P. Occupational exposure to pesticides and multiple myeloma in the AGRICAN cohort. Cancer Causes Control. 2019 Nov;30(11):1243-1250. doi:10.1007/s10552-019-01230-x.